Nexentis Technologies Inc. (NXTS) Fair Value & Analysis
Basic Materials · US · Market cap $3.7M
What is Nexentis Technologies Inc. really worth?
Nexentis Technologies Inc.
NXTS · US
Below-average quality, and trading another 95% above our fair value of $0.8600.
Risks
Fair value as of: Aug 19, 2026
From 1 valuation models · updated 16 days ago
Fair value updated Aug 19, 2026, revised from $0.8200 to $0.8600 (+4.9%) since Aug 13, 2026. Share price −16.8% over the past month.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
What matters now
- The price sits above even our optimistic bull case ($1.08). The favourable scenario is already priced in.
- Weak quality (26/100) and above fair value at the same time, the margin of safety is missing on both counts.
- The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
- A fairly wide model range ($0.5700 to $1.08) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 19, 2026.
How to read this chart
60‑month range $1.48 – $18,008 · fair‑value band $0.5700 – $1.08 · the $1.68 price screens above the $0.8600 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 19, 2026.
Analysis
Nexentis Technologies Inc. (NXTS) currently trades at $1.68, while our model-based Fair Value estimate is $0.8600, implying the stock looks roughly 95.4% overvalued today. The Quality Score stands at 26/100 (below-average quality), in the Basic Materials sector. How firm this estimate is: it rests on 1 models at a data quality of 93/100, which puts the evidence level at low.
Trailing-twelve-month revenue stands at $209K. Revenue declined 77.8% year over year. The balance sheet holds a net cash position of $2.8M. Fundamentals as of Aug 19, 2026
Our scenario range runs from $0.5700 (bear case) to $1.08 (bull case); at $1.68, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. For context, the median of 10 Basic Materials peers we cover trades at 9% fair-value upside, at −49%, NXTS screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.
All 1 models by family
Notify me when NXTS reaches fair value
Put NXTS on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.
Set up alert →Free, no payment details. Unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 19, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 32 · Market factors (momentum, volatility) 1
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.
About the company
Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects.
Full company description
Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The company's pipeline includes MITOLINE, an algorithm used to perform multiple sequence/ structure pairwise alignments which could then be used for generating a 3D comparative model of potentially all mitochondrial carrier proteins; cloud-based computational chemistry platform; and novel in-vitro screening platforms; and advanced 3D NSCLC tumor spheroid systems.The company was formerly known as N2OFF, Inc. and changed its name to Nexentis Technologies Inc. in February 2026. Nexentis Technologies Inc. was incorporated in 2009 and is headquartered in Ness Ziona, Israel.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Nexentis Technologies Inc. reported revenue of $0 in FY2025 versus $438K in FY2021. Reported net income was −$4.0M in FY2025.
NXTS screens 95% overvalued. Compare with Corteva, Inc →
Peer Group
Agricultural Inputs · 178 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Agricultural Inputs median · lower = cheaper
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Agricultural Inputs stocks, each showing price versus our Fair Value estimate (as of Aug 19, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Corteva, Inc CTVA | $78.57 | $27.81 | −65% |
| Nutrien Ltd NTR | C$103.71 | C$113.16 | +9% |
| Qinghai Salt Lake Industry Co 000792 | ¥27.65 | ¥21.26 | −23% |
| CF Industries Holdings CF | $125.79 | $161.00 | +28% |
| SABIC Agri-Nutrients Company 2020 | 122.90 SAR | 127.31 SAR | +4% |
| Yara International ASA YAR | kr 437.20 | kr 630.39 | +44% |
| Yunnan Yuntianhua Co 600096 | ¥31.58 | ¥42.12 | +33% |
| The Mosaic Company MOS | $23.60 | $28.68 | +22% |
| Asia-potash International Investment (Guangzhou)Co.,Ltd., 000893 | ¥45.86 | ¥38.01 | −17% |
| ICL Group ICL | $5.47 | $2.98 | −46% |
Compare Nexentis Technologies Inc. with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Basic Materials stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Nexentis Technologies Inc. (NXTS) overvalued or undervalued?
What is the fair value of NXTS?
What is the quality score of NXTS?
What is the revenue of Nexentis Technologies Inc. (NXTS)?
What is the net profit margin of NXTS?
Watch Nexentis Technologies Inc. in the live analysis
One click puts Nexentis Technologies Inc. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.